| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $18.1M | -9.9% |
| Cost of Revenue | $13.6M | -12.2% |
| Gross Profit | $4.6M | -2.3% |
| R&D Expense | $203K | -26.7% |
| SG&A Expense | $3.6M | +0.8% |
| Operating Income | -$1.1M | +30.3% |
| Pre-tax Income | -$948K | +30.9% |
| Income Tax | $0 | — |
| Net Income | -$948K |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Accounts Receivable | $1.5M | +39.7% |
| Inventory | $2.1M | -33.7% |
| Current Assets | $9.4M | -5.1% |
| Total Assets | $10.9M | +3.5% |
| Current Liabilities | $5.1M | +6.2% |
| Total Liabilities | $6.0M | +25.3% |
| Stockholders' Equity | $4.9M | -14.9% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $437K | +154.9% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | $0 | +100.0% |
| Free Cash Flow | $437K | +154.1% |
| +30.9% |
| EPS (Basic) | -$0.10 | +23.1% |